Cardiovascular and VTE Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases

This systematic review and meta-analysis assesses the risk of all-cause mortality, major adverse cardiovascular events, and venous thromboembolism (VTE) with JAK inhibitors in patients with dermatologic conditions.
Source: JAMA Dermatology - Category: Dermatology Source Type: research